Cargando…
Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal
The use of immunohistochemistry (IHC) as a companion diagnostic is an increasingly important part of the case workup by pathologists and is often central to clinical decision making. New predictive molecular markers are constantly sought for to improve treatment stratification parallel to drug devel...
Autores principales: | Tessier-Cloutier, Basile, Cai, Ellen, Schaeffer, David F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587260/ https://www.ncbi.nlm.nih.gov/pubmed/31221175 http://dx.doi.org/10.1186/s13000-019-0843-z |
Ejemplares similares
-
ARID1B Immunohistochemistry Is an Important Test for the Diagnosis of Dedifferentiated and Undifferentiated Gynecologic Malignancies
por: Tessier-Cloutier, Basile
Publicado: (2023) -
Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence
por: Tsivgoulis, Georgios, et al.
Publicado: (2021) -
Off-label use in germany - a current appraisal of gynaecologic university departments
por: Ditsch, N, et al.
Publicado: (2011) -
Biomarkers for Lupus Nephritis: A Critical Appraisal
por: Mok, Chi Chiu
Publicado: (2010) -
Biomarkers and severe asthma: a critical appraisal
por: Chiappori, Alessandra, et al.
Publicado: (2015)